What are the indications for dual kidney transplantation?

Indications for Dual Kidney Transplantation

Dual kidney transplantation (DKT) is indicated when using marginal or extended criteria donor (ECD) kidneys that would provide insufficient nephron mass if transplanted singly, typically from donors >60 years old or with significant comorbidities (diabetes, hypertension, proteinuria), particularly when pre-implantation biopsy shows substantial chronic histologic damage. 1, 2

Primary Indications

Donor-Related Criteria

Marginal kidneys meeting specific thresholds should be allocated as dual transplants rather than discarded:

• Donor age >60 years with otherwise acceptable organ quality 2
• Donors with diabetes, hypertension, or non-nephrotic proteinuria 2
• High Kidney Donor Profile Index (KDPI) scores - typically >85% 1
• Pre-implantation biopsy showing significant chronic damage:
  • Combined Karpinski score ≥9 can still achieve acceptable outcomes when transplanted as DKT 3
  • Glomerulosclerosis ranging 7-30% 4
  • Histologic damage that would preclude single transplantation 2

Functional Assessment Criteria

Kidneys with borderline viability testing results that are unsuitable for solitary transplantation but collectively provide adequate nephron mass 5. This is particularly relevant for:

• Non-heart-beating donors (NHBD) with prolonged warm ischemia 5
• Donation after circulatory death (DCD) donors 4

Recipient Selection

Optimal recipients for DKT include:

• Older recipients (typically >60-65 years) who match the donor age profile 6
• Patients with lower estimated post-transplant survival (EPTS) scores 6
• Recipients who can accommodate bilateral kidney placement surgically 4

The donor/recipient body weight ratio is the most significant predictor of post-transplant renal function, so matching body size is critical 2.

Technical Considerations

Two surgical approaches are viable:

1. Bilateral extraperitoneal placement - both kidneys placed in separate iliac fossae 4
2. Unilateral placement - both kidneys placed on one side 4

Operating times range 4-7 hours, longer than single transplants but with comparable complication rates 4.

Expected Outcomes

When properly selected, DKT achieves:

• Comparable or superior renal function to single kidney transplants from ideal donors 2, 3
• Mean serum creatinine 1.56 mg/dL at long-term follow-up (actually lower than single transplants at 1.74 mg/dL) 2
• Graft survival rates: 93.5% at 1 year, 90.5% at 5 years, 84.1% at 10 years 7
• Patient survival: 97.9% 6
• eGFR 46-80 mL/min/1.73m² at 6-12 months 3, 4, 7

Critical Pitfalls to Avoid

Do not use DKT for:

• Kidneys with severe vascular abnormalities requiring complex reconstruction (though dual endarterectomy has been reported successfully in select cases) 4
• Recipients <60 years who could benefit from higher-quality single organs, as this disadvantages younger patients on the waitlist 6

Common complications include:

• Delayed graft function (17-21% incidence, comparable to single transplants) 2, 6, 7
• Post-transplant thrombotic microangiopathy (more frequent in DKT) 3
• Primary non-function (6.4%, only in DECD group) 7

Context: Combined Liver-Kidney Transplantation

The provided evidence predominantly addresses combined liver-kidney transplantation (CLKT), which has different indications than DKT alone 8:

CLKT medical eligibility requires:

• CKD with GFR ≤60 mL/min for >3 months, PLUS
• Regular hemodialysis, OR
• GFR ≤30 mL/min at registration, OR
• Dialysis ≥6 weeks, OR
• GFR ≤25 mL/min for ≥6 weeks, OR
• Specific metabolic diseases (hyperoxaluria, aHUS, familial amyloidosis, methylmalonic aciduria) 8

Note: Recent studies show inferior outcomes when using dual kidneys in CLKT, though case reports demonstrate long-term success is possible 8. This represents a distinct clinical scenario from standard DKT.

Allocation Strategy

Since 2019, UNOS guidelines support DKT allocation to reduce organ discard 1. Currently, >60% of adult deceased donor kidneys meeting dual allocation criteria are not transplanted, representing a massive missed opportunity 1. The annual volume in the US is approximately 60 DKTs, though this has declined over the past decade 1.

The key principle: DKT converts otherwise discarded organs into functioning transplants with acceptable outcomes, expanding the donor pool without compromising recipient safety when selection criteria are rigorously applied.